216 related articles for article (PubMed ID: 31687076)
21. Nrf1 and Nrf2 regulate rat glutamate-cysteine ligase catalytic subunit transcription indirectly via NF-kappaB and AP-1.
Yang H; Magilnick N; Lee C; Kalmaz D; Ou X; Chan JY; Lu SC
Mol Cell Biol; 2005 Jul; 25(14):5933-46. PubMed ID: 15988009
[TBL] [Abstract][Full Text] [Related]
22. Suppressive role of microRNA-130b-3p in ferroptosis in melanoma cells correlates with DKK1 inhibition and Nrf2-HO-1 pathway activation.
Liao Y; Jia X; Ren Y; Deji Z; Gesang Y; Ning N; Feng H; Yu H; Wei A
Hum Cell; 2021 Sep; 34(5):1532-1544. PubMed ID: 34117611
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological significance of nuclear factor (erythroid-2)-related factor 2 (Nrf2) expression in gastric cancer.
Kawasaki Y; Ishigami S; Arigami T; Uenosono Y; Yanagita S; Uchikado Y; Kita Y; Nishizono Y; Okumura H; Nakajo A; Kijima Y; Maemura K; Natsugoe S
BMC Cancer; 2015 Jan; 15():5. PubMed ID: 25588809
[TBL] [Abstract][Full Text] [Related]
24. Crosstalk between NRF2 and Dicer through metastasis regulating MicroRNAs; mir-34a, mir-200 family and mir-103/107 family.
Nabih HK
Arch Biochem Biophys; 2020 Jun; 686():108326. PubMed ID: 32142889
[TBL] [Abstract][Full Text] [Related]
25. Integrated Genomics Identifies miR-32/MCL-1 Pathway as a Critical Driver of Melanomagenesis: Implications for miR-Replacement and Combination Therapy.
Mishra PJ; Mishra PJ; Merlino G
PLoS One; 2016; 11(11):e0165102. PubMed ID: 27846237
[TBL] [Abstract][Full Text] [Related]
26.
Akdemir B; Nakajima Y; Inazawa J; Inoue J
Mol Cancer Res; 2017 Nov; 15(11):1570-1578. PubMed ID: 28760781
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of miR-200a protects cardiomyocytes against hypoxia-induced apoptosis by modulating the kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 signaling axis.
Sun X; Zuo H; Liu C; Yang Y
Int J Mol Med; 2016 Oct; 38(4):1303-11. PubMed ID: 27573160
[TBL] [Abstract][Full Text] [Related]
28. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
[TBL] [Abstract][Full Text] [Related]
29. Association of galectin-3 expression with melanoma progression and prognosis.
Brown ER; Doig T; Anderson N; Brenn T; Doherty V; Xu Y; Bartlett JM; Smyth JF; Melton DW
Eur J Cancer; 2012 Apr; 48(6):865-74. PubMed ID: 22071132
[TBL] [Abstract][Full Text] [Related]
30. Redox-metabolic reprogramming of skin in mice lacking functional Nrf2 under basal conditions and cold acclimation.
Zakic T; Stojanovic S; Jankovic A; Korac A; Pekovic-Vaughan V; Korac B
Biofactors; 2023; 49(3):600-611. PubMed ID: 36585756
[TBL] [Abstract][Full Text] [Related]
31. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
Larsen AC
Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
[TBL] [Abstract][Full Text] [Related]
32. miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-κB signaling in gastric carcinogenesis.
Huang T; Kang W; Zhang B; Wu F; Dong Y; Tong JH; Yang W; Zhou Y; Zhang L; Cheng AS; Yu J; To KF
Mol Cancer; 2016 Jan; 15():9. PubMed ID: 26801246
[TBL] [Abstract][Full Text] [Related]
33. A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients.
Ono S; Oyama T; Lam S; Chong K; Foshag LJ; Hoon DS
Oncotarget; 2015 Mar; 6(9):7053-64. PubMed ID: 25749524
[TBL] [Abstract][Full Text] [Related]
34. Redox sensitive miR-27a/b/Nrf2 signaling in Cr(VI)-induced carcinogenesis.
Wang L; Bayanbold K; Zhao L; Wang Y; Adamcakova-Dodd A; Thorne PS; Yang H; Jiang BH; Liu LZ
Sci Total Environ; 2022 Feb; 809():151118. PubMed ID: 34718002
[TBL] [Abstract][Full Text] [Related]
35. microRNA-10b is a prognostic biomarker for melanoma.
Saldanha G; Elshaw S; Sachs P; Alharbi H; Shah P; Jothi A; Pringle JH
Mod Pathol; 2016 Feb; 29(2):112-21. PubMed ID: 26743475
[TBL] [Abstract][Full Text] [Related]
36. MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma.
Zehavi L; Schayek H; Jacob-Hirsch J; Sidi Y; Leibowitz-Amit R; Avni D
Mol Cancer; 2015 Mar; 14():68. PubMed ID: 25889255
[TBL] [Abstract][Full Text] [Related]
37. Anti-angiogenic role of microRNA-23b in melanoma by disturbing NF-κB signaling pathway
Lv R; Yu J; Sun Q
Future Oncol; 2020 Apr; 16(10):541-458. PubMed ID: 32107941
[No Abstract] [Full Text] [Related]
38. Long-isoform NRF1 protects against arsenic cytotoxicity in mouse bone marrow-derived mesenchymal stem cells by suppressing mitochondrial ROS and facilitating arsenic efflux.
Lou B; Hu Y; Lu X; Zhang X; Li Y; Pi J; Xu Y
Toxicol Appl Pharmacol; 2020 Nov; 407():115251. PubMed ID: 32980394
[TBL] [Abstract][Full Text] [Related]
39. MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil.
Shi L; Wu L; Chen Z; Yang J; Chen X; Yu F; Zheng F; Lin X
Cell Physiol Biochem; 2015; 35(6):2333-48. PubMed ID: 25896253
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-200a controls Nrf2 activation by target Keap1 in hepatic stellate cell proliferation and fibrosis.
Yang JJ; Tao H; Hu W; Liu LP; Shi KH; Deng ZY; Li J
Cell Signal; 2014 Nov; 26(11):2381-9. PubMed ID: 25049078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
